Arthritis Completed Phase 3 Trials for Adalimumab (DB00051)

Also known as: Articular inflammation / Unspecified osteoarthritis, unspecified site / Inflammatory arthritis / Arthritis (disorder) / Arthritis NOS

DBCOND0016433 (Arthritis)Completed3 IdentifierTitlePurposeDrugs
NCT00646178Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug TherapyTreatment